An expert-to-expert podcast series on advances in the management of HER2-positive NSCLC, designed for time-pressured clinicians.
Episode 1 will explore HER2 biomarker testing in NSCLC, looking at current guidelines, distinguishing between HER2 alterations, and practical steps for testing amid real-world barriers.
Duration: 20 minutes
Episode 2 will cover the practical considerations for implementing HER2-targeted therapies in the treatment of HER2-positive NSCLC, including their integration into treatment pathways, patient selection, monitoring and managing toxicities, and the role of multidisciplinary collaboration.
Duration: 20 minutes
The third and final episode will look at the future directions in HER2-positive NSCLC; ongoing clinical trials, emerging novel agents in development, and the role of HER2-targeted therapies in first-line management, with expert perspectives on what lies ahead.
Duration: 20 minutes
